Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.
about
Hip region muscular dystrophy and emergence of motor deficits in dysferlin-deficient Bla/J mice.Progress and challenges in diagnosis of dysferlinopathy.Homozygosity of the Dominant Myotilin c.179C>T (p.Ser60Phe) Mutation Causes a More Severe and Proximal Muscular Dystrophy.Mutation in the caveolin-3 gene causes asymmetrical distal myopathy.
P2860
Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.
@ast
Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.
@en
type
label
Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.
@ast
Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.
@en
prefLabel
Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.
@ast
Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.
@en
P2093
P2860
P1433
P1476
Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.
@en
P2093
Angela Huebner
Dirk Fischer
Elisabeth J Rushing
Hans H Jung
Jens A Petersen
Johannes A Lobrinus
Maja von der Hagen
Michael Sinnreich
Veronika Kana
Wolfram Kress
P2860
P2888
P356
10.1186/S12883-015-0449-3
P577
2015-10-06T00:00:00Z
P5875
P6179
1004777428